Curis stock trades 1.45 percent below EUR 0.69 prior close

Curis (ISIN US2312694084) was trading at EUR 0.68 at Lang & Schwarz on October 6, 2026 at 1:59 p.m. CEST, down 1.45 percent versus the EUR 0.69 prior close. The next dated marker is Curis' earnings report scheduled for November 11, 2026, according to Investing.com.

Stock remains close to its low

The Lang & Schwarz quote places Curis EUR 0.01 below the prior close, a decline of 1.45 percent for the October 6 session. That comparison gives investors a clear near-term reference while the US listing remains the primary market for the biotechnology company.

Curis had a USD 1.5 million market capitalization as of October 5, 2026. Its USD 0.72 to USD 34.00 52-week range shows a wide spread between the latest primary-market context and the yearly high, while the Lang & Schwarz price remains a separate euro quotation.

November results set the next marker

The November 11 reporting date is the next scheduled company event identified for Curis. The date matters because the company is operating at a clinical-development stage, where trial progress and financing conditions can influence valuation more directly than recurring commercial revenue.

Curis' investor-relations page describes the company as focused on cancer therapeutics and identifies emavusertib as its lead development program. The same page also lists the TakeAim CLL study update from July 30, 2026 and the August 13, 2026 pricing of a USD 5.6 million public offering, giving the upcoming report a pipeline and funding context, according to Curis.

Clinical data drive the investment case

Curis is developing emavusertib, an oral small-molecule IRAK4 and FLT3 inhibitor, for cancer indications. Its pipeline also includes programs aimed at lymphoma and immune-oncology applications, making clinical milestones a central valuation factor.

The company trades under the CRIS ticker on NASDAQ. For investors, the key numerical contrast is immediate: EUR 0.68 at Lang & Schwarz against EUR 0.69 at the prior close, alongside a USD 0.72 to USD 34.00 annual range in the primary-market data.

Curis trades below prior close

Curis was trading at EUR 0.68 at Lang & Schwarz on October 6, 2026 at 1:59 p.m. CEST, down 1.45 percent versus the EUR 0.69 prior close. The next scheduled earnings date is November 11, 2026.

More news and analyses on Curis stock